Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetes
Abstract Patients with diabetes have a high risk of failure of H. pylori eradication therapy. The present study aims to evaluate the efficacy and safety of vonoprazan–amoxicillin (VA) dual therapy for the treatment of H. pylori infection in patients with type-2 diabetes mellitus (T2DM), and determin...
Saved in:
Main Authors: | Jie Zhang, Xin Cao, Kai Ma, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-85628-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helicobacter pylori: pathogenesis
by: P. Sabanas, et al.
Published: (2024-09-01) -
High-dose dual therapy for Helicobacter pylori eradication inducing less impact on the gut microbiota
by: Jia-Lun Guan, et al.
Published: (2025-01-01) -
Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01) -
Characterization of Helicobacter Pylori Infection in Patients with Gastric Ulcer
by: Marcos Félix Osorio Pagola, et al.
Published: (2009-12-01) -
Review of non-Helicobacter pylori Helicobacter species: Insights into pathogenesis, epidemiology, and clinical implications
by: M. Kroiß, et al.
Published: (2024-09-01)